Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - imatinibum - compresse rivestite con film - imatinibum 100 mg ut imatinibi mesilas, calcii hydrogenophosphas, crospovidonum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (flavum), pro compresso obducto. - onkologikum - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - fedratinibum - capsule rigide - fedratinibum 100 mg ut fedratinibi dihydrochloridum monohydricum, cellulosum microcristallinum silicificatum, natrii stearylis fumaras corresp. natrium 0.18 mg, kapselhülle: gelatina, e 172 (rubrum), e 171, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - primäre oder sekundäre myelofibrose - synthetika

Itālija - itāļu - AIFA (Agenzia Italiana del Farmaco)

pfizer italia s.r.l. - metoprololo e tiazidi - metoprololo e tiazidi

Itālija - itāļu - AIFA (Agenzia Italiana del Farmaco)

sigma-tau industrie farmaceutiche riunite spa - metoprololo - metoprololo

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

orion pharma ag - salbutamolum - polvere per inalazione - salbutamolum 100 µg di salbutamoli sulfas, lactosum monohydricum, per la polvere per le dosi, dosi per una nave di 200. - bronchospasmolytikum - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - celecoxibum - capsule rigide - celecoxibum 100 mg, lactosum monohydricum 149.7 mg, natrii laurilsulfas, povidonum k 30, carmellosum natricum conexum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, e 132, pro capsula corresp., natrium 0.71 mg. - inibitore selettivo cox-2 inibitori - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - imatinibum - compresse rivestite con film (divisibile) - imatinibum 100 mg ut imatinibi mesilas, cellulosum microcristallinum, crospovidonum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, e 172 (rubrum), e 172 (flavum), macrogolum 4000, talcum, pro compresso obducto. - prescritti; ph+ mieloide cronica leucemia (ph+cml); ph+ la leucemia linfatica acuta (ph+all); hypereosinophilensyndrom (hes/cel); atipici myelodysplastische/myeloproliferative malattie (mds/mpd); aggressivo mastocitosi sistemica (aggr. sm); gastrointestinali, tumori stromali possono (gist); dermatofibrosarkom protuberans (dfsp); (per informazioni dettagliate sull'indicazione di vedere la corrente riassunto delle caratteristiche del prodotto) - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - lantanio - compresse masticabili - lanthanum 1000 mg ut lanthani(iii) carbonas hydricum 1908 mg, saccharida hydrica corresp. glucosum 2111.472 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. - sostanza che lega il fosfato - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - celecoxibum - capsule - celecoxibum 100 mg, calcii hydrogenophosphas dihydricus, natrii laurilsulfas corresp. natrium 0.1 mg, crospovidonum, povidonum k 30, povidonum k 90, magnesii stearas, kapselhülle: gelatina, aqua, e 171, drucktinte: lacca, propylenglycolum, e 132, pro capsula. - inibitore selettivo cox-2 inibitori - synthetika

Šveice - itāļu - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - celecoxibum - capsule rigide - celecoxibum 100 mg, lactosum monohydricum 149.75 mg, povidonum k 30, carmellosum natricum conexum, natrii docusas, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.626 mg. - inibitore selettivo cox-2 inibitori - synthetika